- cafead   Feb 02, 2023 at 11:12: PM
via In 2023, four major trials in influenza, genital herpes, and melanoma will show just how far-reaching mRNA vaccine technology could be. These include Moderna’s mRNA-1010 and Pfizer’s modRNA vaccine in seasonal influenza, Roche/BioNTech’s RO7198457 in advanced melanoma, and BioNTech’s BNT-163 for lesions in genital herpes.
article source
article source